DARE - Brookline Capital upgrades Dare Bioscience cites improved funding
2024-05-15 13:54:48 ET
More on Dare Bioscience
- Daré Bioscience, Inc. (DARE) Q1 2024 Earnings Call Transcript
- Daré Bioscience, Inc. (DARE) Q4 2023 Earnings Call Transcript
- Dare Bioscience GAAP EPS of -$0.07
- Daré Bioscience secures $22 million in non-dilutive strategic royalty financing
- Seeking Alpha’s Quant Rating on Dare Bioscience